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Factors influencing treatment success of
negative pressure wound therapy in
patients with postoperative infections after
Osteosynthetic fracture fixation
Kaywan Izadpanah1, Stephanie Hansen1, Julia Six-Merker2, Peter Helwig1, Norbert P Südkamp1
and Hagen Schmal1,3*
Abstract
Background: Negative Pressure Wound Therapy (NPWT) is being increasingly used to treat postoperative infections
after osteosynthetic fracture fixation. The aim of the present study was to analyze the influence of epidemiological
and microbiological parameters on outcome.
Methods: Infections following operative fracture fixation were registered in a comprehensive Critical Incidence
Reporting System and subsequently analyzed retrospectively for characteristics of patients including comorbidity,
bacteria, and clinical factors. The influence of the investigated parameters was analyzed using logistic regression
models based on data from 106 patients.
Results: Staged wound lavage in combination with NPWT allowed implant preservation in 44% and led to successful
healing in 73% of patients. Fermentation characteristics, load and behavior after gram staining revealed no statistically
significant correlation with either healing or implant preservation. Infecting bacteria were successfully isolated in 87% of
patients. 20% of all infections were caused by bacterial combinations. We observed a change in the infecting bacterial
species under therapy in 23%. Age, gender, metabolic diseases or comorbidities did not influence the probability of
implant preservation or healing. The delayed manifestation of infection (>4 weeks) correlated with a higher risk for
implant loss (OR 5.1 [95% CI 1.41–17.92]) as did the presence of bacterial mixture (OR 5.0 [95% CI 1.41–17.92]) and open
soft-tissue damage ≥ grade 3 (OR 10.2 [CI 1.88–55.28]). Wounds were less likely to heal in conjunction with high CRP
blood levels (>20 mg/l) at the time of discharge (OR 3.6 [95% CI 1.31–10.08]) or following a change of the infecting
bacterial species under therapy (OR 3.2 [95% CI, 1.13–8.99]).
Conclusions: These results indicate that the delayed manifestation of infection, high CRP blood levels at discharge, and
alterations in the infecting bacterial species under therapy raise the risk of NPWT failure.
Keywords: Infection, Osteosynthesis, Npwt, Vac, Clinical trial, Logistic regression models
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Background
Infections in trauma surgery are considered severe com-
plications, because they often lead to persistent disability
even in young patients, usually due to osteomyelitis or
septic non-union. Several treatment approaches have
been developed during recent decades, such as open
wound treatment and the application of synthetic skin
substitutes for wound closure as Grafix® (1) or NIKS-
Based Bioengineered Skin Substitute Tissue (2). These
procedures are all accompanied by the debridement of
necrotic tissue to initiate regeneration of the surround-
ing soft tissue [1]. A modern treatment option for com-
plex wounds (including traumatic injuries [2]) is to apply
negative wound therapy delivered via the vacuum-
assisted wound closure (VAC) therapy system [3]. VAC
therapy has proven to be effective in the treatment of
chronic wounds, including complex diabetic foot ulcera-
tions [4, 5], resulting in a higher proportion of healed
wounds, faster healing rates, and potentially fewer am-
putations compared with standard care. Other successful
applications include the reliable fixation of mesh-grafts
in reconstructive surgery [6], treatment of sternal osteo-
myelitis [7], and the closure of burn wounds [8]. Fur-
thermore, NPWT appears to be a valuable adjunct for
the treatment of traumatic wounds [9], reducing the
number of necessary free muscle transfers, fasciocuta-
neous flaps or osteocutaneous flaps [10]. In addition to
the treatment of traumatic wounds, NPWT therapy has
become a basic procedure when treating postoperative
infections after the open reduction and internal fixation
of bone fractures.
Being located in different regions of the body, postop-
erative infections after osteosynthesis are multifaceted,
and patients differ in their epidemiologic characteristics
and comorbidities such as metabolic diseases. Moreover,
the vast diversity in bacterial parameters (e.g. bacterial
combination, identification of bacteria, changes in mi-
crobial strains during treatment) and soft-tissue traumas
must be confronted during treatment.
This includes biofilm formation typically seen after infec-
tions with staphylococcus species. Bacteria adhere to the
implants, form these extracellular polymers and, by this,
are a major reason for bacterial persistence. This requires
different treatment options including new generations
of antimicrobial strategies (3). Furthermore, the diag-
nostic reliability of different sample drawing tech-
niques and subsequent processing has been discussed
extensively. Hereby, biopsies and culture of synovial
fluid in blood culture vials has been shown to be
more sensitive (90–92%) than intraoperative swab cul-
tures (68–76%) (4).
The influence of these parameters on NPWT therapy’s
effectiveness in postoperative infections following open
reduction and internal fixation (ORIF) is unknown.
We therefore hypothesized that NPWT is a suitable
supplement to support surgical treatment of postopera-
tive wound infections. A further aim of this study was to
analyze the impact of certain factors on the outcome
after the treatment of infected osteosynthesis using
NPWT therapy. To describe the outcome, we chose the
parameters infection cure, implant survival, and the type
of final wound closure. Primarily, we hypothesized that
the efficacy of NPWT therapy in treatment of infections
is influenced by parameters characterizing the infecting
bacteria as gram staining or metabolism. Secondary, we
hypothesized an influence of epidemiological parame-
ters. Since the C-reactive protein is known as a reliable
biomarker for monitoring acute inflammation [11] and
postoperative healing success [12], this study further
sought to address, whether there is a diagnostic thresh-
old for the evaluation of healing in implant-associated
infection.
Methods
Patients
All patients suffering an infection following open reduc-
tion and internal fixation who underwent NPWT ther-
apy at our hospital were continuously registered using a
Critical Incidence Reporting System (CIRS) over a
period of 9 years (from 2001 to 2009) as described previ-
ously [13]. Our department used a noncommercial CIRS,
which also provided a variety of other features, as a
complication database. The first registration of a compli-
cation is done in the local documentation program of
the Surgical Department (PROMetheus, Klinikrechen-
zentrum Freiburg, Germany). However, data were ana-
lyzed retrospectively. The recorded data are primarily
documented by the treating surgeons, then checked for
completeness and integrity by a database manager, and
then randomly monitored during the quality control
process twice a year (certification following DIN EN ISO
9001 by SGS-International Certification Services GmbH,
Hamburg, Germany). Electronic documentation of surgi-
cal procedures included ICD and OPS codes and indica-
tions of postoperative complications. We requested a list
of patients who had suffered postoperative infections
after osteosynthesis and extracted those patients who
had undergone NPWT/VAC therapy from the list. All
those patients were included in the present study except
those with pathologic fractures.
VAC procedures were evaluated regarding the infec-
tion’s successful healing (A), type of wound closure (B)
and survival or preservation of the implant (C). These
three categories were our outcome parameters. Two
groups of wound closure were defined: group 1 included
secondary wound closure and mesh-graft coverage,
group 2 included all types of soft tissue coverage such as
muscle flaps or full skin transplantations.
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The data are presented as a retrospective consecutive
case series based on reviewing a database (CIRS), con-
taining continuously registered complications. Data was
exported from the CIRS as it contains all VAC-treated
infections at the authors’ institution. Over the docu-
mented years, the own infection rate pretty constantly
ranged around 1.1%. Parameters such as patient charac-
teristics (age, sex, co-morbidities, metabolic diseases), in-
fection parameters (initial, maximum, and discharge
CRP during hospitalization for revision surgery; time of
infection, i.e. early onset [≤4 weeks] and late onset infec-
tion and extent of infection (soft tissue damage), bacter-
ial parameters (gram stain, bacterial metabolism
[fermentation], bacterial load, polymicrobial infection)
and treatment parameters (intensive care unit stay in
days, number of lavages until eradication [number of
sponge changes; since all patients initially were
treated by NPWT, 0 means that the sponge was ap-
plied once, but never changed], outcome of the im-
plant [preservation or survival], re-infection) (see
Table 1 for more information) were determined. All
included cases were followed until either the infection
has resolved or another definitive status had been
documented such as amputation or chronic osteomye-
litis. Overall, the follow-up of all patients was at least
one year. The evaluation of the soft tissue damage
was done according to the classification of Oestern
and Tscherne, is a standard of the documentation,
and was evaluated by the treating surgeon. The num-
ber of registered complications is a key process in-
dicator for the certified quality management at our
institution (ISO 9001®, KTQ®) and is required for
yearly external audits; these data are therefore moni-
tored regularly. This project was approved by our in-
stitutional ethical committee, and patients provided
written informed consent for the use of their data for
process control and scientific analysis.
Treatment protocol
All patients included in the present study had undergone
surgery. Staged lavage (every four to five days), local de-
bridement and vacuum-assisted closure were performed
with no exception. For Negative Pressure Wound Ther-
apy (NPWT) exclusively products produced by KCI
(KCI Medizinprodukte GmbH, Wiesbaden, Germany)
were used. All wounds were treated by delivering of
negative pressure at the wound site only without rinsing
(no KCI V.A.C. Instill).
During each operative procedure, up to 5 superficial
(subcutis) and deep smear tests (layer with osteosynth-
esis) were performed with pieces of debrided tissue for
each patient. This was adapted and decided by the oper-
ating surgeon dependent on the local and the clinical
situation and the verified bacterial infection status. The
indication for each operative revision was based on local
signs of infection such as pain, redness, pus, swelling, a
foul odor, drainage or heat at the site combined with ele-
vated serologic inflammatory parameters such as the
leukocytic cell count and C-reactive protein (CRP). The
indication for implant removal was given in case of per-
sistent infection with clinical symptoms or insufficient
soft tissue coverage. Antibiotic treatment was started in
all cases with second-generation cephalosporin. If the
bacteria were identifiable, the infection was treated with
bacteria-specific antibiotics, and the pharmaceuticals
were adapted accordingly. In cases of multi-resistant
Staphylococcus aureus infections, vancomycin was se-
lected for antibiosis. Patients presenting Pseudomonas
aeruginosa infection underwent a specific antibiotic
treatment according to tests of resistance. All other pa-
tients received continuous antibiotic treatment with
second-generation cephalosporin. Indications for wound
closure were negative smear tests from the previous op-
eration, decreasing CRP blood levels and clinically good
granulation of the wound base. If soft tissue conditions
Table 1 List of influencing parameters and outcome parameters defined in this study
Influencing parameters
(Independent variables)
• Patient parameters:
sex, age, co-morbidities, metabolic diseases (kidney diseases, liver diseases, diabetes mellitus)
• Infection parameters:
initial C-reactive protein (CRP), maximum CRP, discharge CRP (≤ 20 mg/l blood versus >20 mg/l)a,
time of infection, extent of infection (superficial/deep), time point of infection
(early [detected up to 4 weeks after surgery] or late onset [detected more than four weeks after surgery]),
soft-tissue damage (according to the Tscherne and Oestern classification)
• Germal parameters:
bacterial mixture, identification of bacteria, change in microbial strain during treatment, gram stain,
bacterial metabolism (aerobic/anaerobic), bacterial load (Group 1 – very high contamination,
Group 2- numerous bacteria, Group 3-isolated bacteria, Group 4-bacteria detectable after enhancement)
• Treatment parameters:
Intensive care unit-stay, number of lavages until eradication, re-infection
Outcome parameters
(Dependent variables)
• cure of infection
• type of wound closure
• preservation or survival of the implant
aCRP-discharge’ was calculated as CRP ≤20 mg/l blood versus >20 mg/l blood at the time of discharge or a change in the infecting bacterial species
under therapy
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allowed adaption of the wound edges, a secondary su-
ture was made. If not, split skin grafts were used for
wound closure. Exposed bones, vessels, or nerves were
covered via microsurgical techniques.
Statistics
For the continuous variables, the mean with the stand-
ard deviation was obtained. Categorical sample charac-
teristics were calculated as frequencies and percentages.
Student’s t-test, the Kruskal-Wallis test, the Chi-Square
test or Fisher’s Exact test was used to test differences in
the patients’ distribution between the outcome parame-
ters and the influencing parameters (see Tables 2 and 3
according to the statistical requirements). The normal
distribution of continuous variables was checked by
plotting a histogram and performing the Kolmogorov-
Smirnov test, whereas the equality of variances was
checked using Levene’s test Parameters with significant
different distribution within the outcome parameters
and sufficient sample size were incorporated initially
into the logistic multiple Regression models. The main
effect models were built using the backward elimination
procedure. Using main effect regression models, the in-
fluence on the outcome parameter a successful restor-
ation of the infection (Model A), the type of wound
closure (Model B), and losing the implant before fracture
healing had occurred (implant survival, Model C) were
determined (Tables 4 and 5). The main effect Model A
contained CRP discharge and change in microbial strain.
Model B ‘type of wound closure’ could not be analysed
due to no variable achieved the requirements. Model C
contained bacterial mixture, time of infection and soft
tissue damage. Results are presented as odds ratios
(ORs) with 95% confidence intervals (CIs). Significance
tests were two-tailed, and P-values lower than 0.05 were
considered statistically significant. Parameters not docu-
mented within the CIRS, such as smoking, were not in-
cluded. Analyses were performed using the statistical
package SAS ® 9.2 (Cary, NC, USA).
Results
General
One hundred and six patients were enrolled in the
present study, most of whom were male (77 males, 29
females). Average age was 54 (SD 19) years. Twenty-two
of these patients suffered from metabolic diseases such
as diabetes mellitus (7/6.7%), hyper- or hypothyroidism
(1/0.9%), renal insufficiency (3/2.8%) or hepatic insuffi-
ciency (9/8.5%). Two patients suffered from chronic
myeloid leukemia, one from laryngeal carcinoma and
two from chronic occlusive disease (Grade 2). Patients
suffering chronic myeloid leukemia received low dose
prednisolone.
In 53 patients a grade 1 closed fracture, in 10 patients
a grade 3 closed fracture, in four patients a grade 1 open
fracture, in 22 patients a grade 2 open fracture and in 17
patients a grade 3 open fracture was documented. 4 Pa-
tients suffered from occlusive arterial disease, in 5 pa-
tients an alcohol addiction was documented. In 9
patients a BMI > 25 was recorded.
The distribution of fractures was as follows: femur
(22/21.0%), lower leg (42/40.0%), foot (12/11.0%), clav-
icle (1/0.9%), upper arm (7/6.6%), forearm (5/4.7%), pel-
vis (6/5.6%), and spine (11/10.4%).
Seventy infections (66.0%) occurred after plate osteo-
synthesis; 20 (18.9%) occurred after osteosynthesis in-
volving only pins, wires or screws; 11 (10.4%) occurred
after implantation of an internal fixator; and 5 (4.7%) oc-
curred after intramedullary nailing.
In 87% of all treated patients, bacteria were isolated dur-
ing primary lavage; a polymicrobial infection was present
in 20% of the cases. Staphylococcus aureus (42/39.6%) and
Staphylococcus epidermidis (12/11.3%) were identified as
the predominant cause of infection. Furthermore, Bacillus
species (5/4.7%), Escherichia coli (2/1.8%), Enterobacter
aerogenes (1/0.9%), Enterobacter cloacae (4/3.6%), Entero-
coccus faecalis (4/3.6%), Enterococcus faecium (2/1.8%),
Methicillin Resistant Staphylococcus aureus (6/5.6%),
Peptostreptococcus species (2/1.8%), Proteus mirabilis
(1/0.9%), Pseudomonas aeruginosa (7/6.3%), Staphylococ-
cus auricularis (1/0.9%), Staphylococcus capitis (1/0.9%),
Staphylococcus haemolyticus (2/1.8%), Staphylococcus
lugdunensis (1/0.9%), Stenotrophomonas maltophilia
(2/1.8%), Streptococcus agalactiae (2/1.8%), and Strepto-
coccus equisimilis (1/0.9%) were isolated. An overview
provides Fig. 1.
Gram staining was positive in 80% of the samples and
negative in 20%. 7.3% of the isolated bacteria were aerobic
germs, 3.1% were anaerobic germs, 79.2% were facultative
anaerobic germs, and 5.2% were facultative aerobic germs.
The microbial strains changed under therapy in 23% of all
cases.
In summary, infection healing was achieved in 73% of
all cases in the present study. A locally controlled osteo-
myelitis persisted in 16% of all cases, and 4% underwent
an amputation. 44% of all implants survived at least until
bony consolidation, and only secondary suturing or
mesh grafting had to be done for wound closure in 78%
of patients.
Curing the infection
There were no significant differences in gender, age, in-
tensive care unit-treatment (ICU-treatment), identifica-
tion of a microbial strain, bacterial load, type of bacteria,
presence of a bacterial mix, CRP at admission to the
hospital, or maximum CRP measured during the stay in
patients whose infection was cured compared to patients
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Table 2 Summary of the collected data displaying distribution of the parameters investigated in the group with a cured infection
and the group without.
Variable Description Cure of infectiona p-valueb
Yes No
n mean or % SD n mean or % SD
Gender Male 56 72.7 21 72.4 0.9743
Female 21 27.3 8 27.6
Age 77 53.2 18.9 29 55.8 17.9 0.5588
Stay at ICU days 77 3.0 5.2 29 5.6 7.3 0.0790
Initial procedure Open 1 1.3 2 6.9 0.1810
Closed 76 98.7 27 93.1
Tissue damage Open Grade 0-2 11 14.3 8 27.6 0.0437
Open Grade 3-4 7 9.1 6 20.7
Closed 59 76.6 15 51.8
Identification of a Yes 66 85.7 26 89.7 0.7535
microbial strain No 11 14.3 3 10.3
Presence of a bacterial mixture Yes 12 15.6 9 31.0 0.2016
No 54 70.1 17 58.6
No detectable germ 11 14.3 3 10.3
Change in microbial strain Yes 65 84.4 17 58.6 0.0047
No 12 15.6 12 41.4
Gram stain Positive 57 74.0 17 58.6 0.0746
Negative 9 11.7 9 31.0
No detectable germ 11 14.3 3 10.4
Bacterial metabolism Aerobic 3 3.8 4 13.8 0.0309
Anaerobic 1 1.3 2 6.9
Facultative anaerobic 60 77.9 16 55.2
Facultative aerobic 2 2.6 3 10.3
No detectable germ 11 14.3 4 13.8
Bacterial load Plentiful 18 23.4 9 31.0 0.9095
Numerous 25 32.5 7 24.1
Sporadic 20 26.0 8 27.6
Enrichment 3 3.9 1 3.4
No detectable germ 11 14.3 4 13.8
Number of lavages until eradication sponge changes 0 33 42.9 18 62.1 0.0431
sponge changes 1 20 26.0 6 20.7
sponge changes 2 14 18.2 0 0.0
sponge changes ≥3 times 8 10.4 3 10.3
Never be eradicated 2 2.6 2 6.9
CRP Initial [mg/l] 72 78.2 92.1 25 69.6 78.4 0.8112
CRP Maximum [mg/l] 76 128.8 101.7 25 137.5 94.6 0.4547
CRP Discharge [mg/l] 75 16.3 23.6 26 46.1 52.1 0.0077
CRP Discharge ≤20 mg/l 58 77.3 12 46.2 0.0036
>20 mg/l 17 22.7 14 53.8
Time point of infection Early 49 63.3 16 57.1 0.5446
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who developed a chronic infection (Table 2). We de-
tected significant differences regarding the presence of
soft tissue damage, a change in microbial strain during
treatment, bacterial metabolism, and the distribution of
CRP at the time of discharge (Table 2).
Due to small case numbers in some subgroups, we
conducted no statistical testing for the influence of the
infection’s location on its cure (data not shown).
In the main effect multiple logistic regression model,
the ORs for patients with a CRP at discharge ≤20 mg/l
and change in microbial strain were 3.6 [95% CI 1.31–
10.08] and 3.2 [1.13–8.99], respectively.
To evaluate the influence of comorbidity, the Charlson
comorbidity index score (CCoMI) was assessed as re-
cently described (5). For reasons of statistical practicabil-
ity, all patients with an CCoMI of 0 (78%) were
compared to all patients with an CCoMI > 0 (22%). Al-
though the infection could be successfully cured in the
first group in 82% and in the second group only in 67%,
there was no statistically significant difference. Further-
more, the analysis of the subgroups with oncological,
cardiovascular, liver or renal comorbidity, polytrauma or
substance abuse failed to show statistical differences, but
resulted only in small sized subgroups.
Types of wound closure
We identified no significant association between any of
the parameters when comparing patients who under-
went a minor reconstructive procedure such as second-
ary wound closure or mesh graft coverage with those
undergoing plastic reconstructive treatment such as
muscle flap coverage.
Preservation (survival) of the implant
When comparing patients whose implants survived with
those whose implants were removed, we observed no
significant difference in the distribution of gender, age,
treatment at an intensive care unit, change in microbial
strain during therapy, identification of a specific bacteria,
bacterial load, CRP at admission to the hospital, max-
imum CRP measured during the stay, CRP at the time
of discharge, metabolic diseases, or extent of soft tissue
damage. Implant survival was statistically significantly
influenced by the presence of a bacterial mixture
(p < 0.05) and by the timing of the infection (primary vs.
secondary) (p < 0.01). When the infection had been
cured, the implant was preserved more often (p < 0.01)
(Table 3). There were no identified maximal numbers of
revisions; despite more than 3 revisions in some cases
the implant could be preserved.
The main effect multiple logistic regression models
revealed that a late-onset infection yielded a 5.1-fold
higher odds ratio [95% CI 1.41–17.92] of losing the
implant before bony consolidation compared with
early-onset postoperative infections. We also noted
further associations between the presence of a bacter-
ial mixture and secondary wound infections (OR 5.0
[95% CI 1.41–17.92] and OR 10.2 [95% CI 1.88–
55.28] for losing the implant before bony consolida-
tion (see Table 5).
Discussion
Key findings of the present study are that the patient’s
age, gender or co-morbidities do not significantly impair
the likelihood of a successfully cured infection, implant
survival until bony consolidation, or the type of wound
closure during NPWT therapy of infected osteosynth-
esis. Moreover, NPWT therapy proved to be equally ef-
fective in gram-positive and gram-negative aerobic and
anaerobic bacteria with regards to our outcome parame-
ters. However, the primary presence of a bacterial mix-
ture or changes in microbial strains during therapy
increased the risk that bony consolidation was only feas-
ible after implant removal. The C-reactive protein serum
level is a good parameter for monitoring the success of
treatment. Indeed, a critical concentration of less than
Table 2 Summary of the collected data displaying distribution of the parameters investigated in the group with a cured infection
and the group without. (Continued)
Late 28 36.7 12 42.9
Extent of infection Superficial 2 2.6 1 3.4 1.000
Deep 75 97.4 28 96.6
Metabolic diseasec Yes 12 15.6 7 24.1 0.3061
No 65 84.4 22 75.9
Re-infection Yes 23 29.9 14 48.3 0.0764
No 54 70.1 15 51.7
Implantat preservation After fracture consolidation 40 53.3 7 24.1 0.0073
Before fracture consolidation 35 46.6 22 75.9
SD = standard deviation, an total = 106, b in all analysis two-tailed tests with a significance level of 0.05 were used, c metabolic diseases = kidney diseases, liver
diseases and diabetes mellitus
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Table 3 Summary of the collected data displaying distribution of the parameters investigated in the group with implant survival/
preservation and the group in whom the implant was removed
Variable Description Survival of the implant until bony consolidationa p-valueb
Yes No
n Mean or % SD n Mean or % SD
Gender Male 38 80.9 37 64.9 0.0712
Female 9 19.1 20 35.1
Age 47 55.5 18.5 57 52.1 18.9 0.3006
Stay at ICU days 47 4.5 6.5 57 3.1 5.5 0.4337
Initial procedure Open 45 95.7 1 1.8 0.5881
Closed 2 4.3 56 98.2
Tissue damage Open Grade 0-2 7 14.9 11 19.3 0.042
Open Grade 3-4 2 4.3 11 19.3
Closed 38 80.9 35 61.4
Identification of a Yes 43 91.5 48 84.2 0.2640
microbial strain No 4 8.5 9 15.8
Presence of a bacterial mixture Yes 5 10.6 15 26.3 0.0413
No 38 80.8 33 57.9
No detectable germ 4 8.5 9 15.8
Change in microbial strain during treatment Yes 40 85.1 40 70.2 0.0721
No 7 14.9 17 29.8
Gram Stain Positive 34 72.3 39 68.4 0.8615
Negative 8 17.0 10 17.5
None 5 10.6 8 14.0
Bacterial metabolism Aerobic 3 6.4 4 7.0 0.2172
Anaerobic 1 2.1 2 3.5
Facultative anaerobic 38 80.9 37 64.9
Facultative aerobic 0 0.0 5 8.8
No detectable germ 5 10.6 9 15.8
Bacterial load Plentiful 10 21.3 17 29.8 0.7030
Numerous 17 36.2 15 26.3
Sporadic 13 27.7 14 24.6
Enrichment 2 4.3 2 3.5
No detectable germ 5 10.6 9 15.8
Number of lavages until eradication sponge changes 0 23 48.9 27 47.4 0.6821
sponge changes 1 13 27.7 13 22.8
sponge changes 2 4 8.5 9 15.8
sponge changes ≥3 times 7 14.9 4 7.0
Never be eradicated 0 0.0 4 7.0
CRP Initial [mg/l] 45 81.5 94.1 50 72.6 85.1 0.7201
CRP Maximum [mg/l] 47 147.6 102.6 52 115.2 95.2 0.2187
CRP Discharge [mg/l] 46 23.2 39.2 53 24.9 32.9 0.6668
CRP Discharge ≤20 mg/l 34 73.9 35 66.0 0.5113
>20 mg/l 12 26.1 18 34.0
Time Point of Infection Early 36 76.6 27 48.2 0.0032
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20 mg/l (norm ≤5 mg/l) appears to indicate successful
treatment of infection.
Implant-associated infections after the treatment of
closed fractures in the skeletal system occur in 0.2–9.0%
[14] of cases, a complication that might be reduced sig-
nificantly by regular perioperative application of single-
injection antibiotics [15]. Variables such as tissue viabil-
ity and damage, the presence of infection, exposed
osteosynthetic material, implant failure, fracture location
and patient-related factors contribute to the lack of gen-
eral consensus regarding the management of these de-
fects [1], [16]. Most authors recommend an initial
radical debridement followed by early implant removal,
permanent drainage [14], the application of local antibi-
otics [17], vacuum-assisted closure (VAC) of the wound,
or a combination of these approaches. There is evidence
that adequate early wound coverage, preferably with vital
tissue, results in fewer infections [18]. We carried out
this study because the efficacy of NPWT therapy had
not been examined in conjunction with the treatment of
fracture implants. Our data show that administering
NPWT therapy for implant-associated infections after
osteosynthetic stabilization facilitates implant preserva-
tion in 44% of cases and healing with secondary wound
closure in 73% of cases, which confirms our initial hy-
pothesis and specifies treatment expectations. The pre-
dominant bacterial strains isolated in the present study,
such as Staphylococcus aureus and Staphylococcus epi-
dermidis, are consistent with other findings regarding
implant-associated infections [19]. NPWT therapy was
known to be effective in the treatment of surgical infec-
tion sites [20], but it was unclear whether the efficacy of
NPWT treatment depended on specific bacterial char-
acteristics such as gram staining or aerobic/anaerobic
metabolism, until now. The potential formation of
biofilms has been identified as a risk factor for per-
sistent and recurrent infections [21], a phenomenon
associated with specific microbial strains. Our data do
not permit us to conclude that those features of bac-
terial biology influence NPWT therapy’s effectiveness
in treating infected implants. Neither the initial bac-
terial load nor initial presence of several bacterial
strains correlated with an unfavorable outcome in our
patients. Not until isolated bacterial strains had chan-
ged during treatment did the risk of implant removal
rise significantly. This result appears to concur with
findings from a prospective randomized trial [22].
That working group demonstrated a positive NPWT-
therapy effect on wound healing that was associated
with a significant reduction in the wound surface
area, although the effect could not be attributed to a
quantitative reduction in the bacterial load [22]. Some
researchers have even reported increased bacterial
colonization during NPWT therapy [23]. Despite this
potentiality, the beneficial effects of this treatment
modality on wound healing outnumber the negative
effects [23]. The present data indicate only indirectly
that biofilm formation is a key, because secondary or
“low grade” infections with delayed diagnosis corre-
lated with significantly lower probability for successful
Table 3 Summary of the collected data displaying distribution of the parameters investigated in the group with implant survival/
preservation and the group in whom the implant was removed (Continued)
Late 11 23.4 29 51.8
Extent of Infection Superficial 0 0.0 2 3.5 0.4998
Deep 47 100.0 55 96.5
Metabolic diseasec Yes 8 17.0 9 15.8 0.8657
No 39 82.0 48 84.2
Re-infection Yes 14 29.8 23 40.4 0.3951
No 33 70.2 34 59.6
Curing the Infection Yes 40 85.1 35 61.4 0.0086
No 7 14.9 22 38.6
SD = standard deviation, an total = 106, missing data on implant survival until bony consolidation n = 2, b in all analysis two-tailed tests with a significance level
of 0.05 were used, c metabolic diseases = kidney diseases, liver diseases and diabetes mellitus
Table 4 Logistic regression models on the outcome parameter “infection cured”
Cure of Infection Multiple logistic regression modela
Influencing Parameters vs. OR [95% CI] p
CRP – discharge ≤ 20 mg/l > 20 mg/l 3.6 [1.31-10.08] 0.0134
Change of microbial strain Yes No 3.2 [1.13-8.99] 0.0289
All p-values presented are two-tailed, and p-values lower than 0.05 were considered statistically significant, 95% confidence level (CI)
aoutcome: infection cured (yes/no), independent variables: CRP – discharge (≤20 mg/l vs. >20mg/l), change in microbial strain (yes/no), and survival of the implant
until bony consolidation (yes/no)
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treatment. However, since we did not analyze biofilm
formation directly, we can only hypothesize that this
is a factor for the higher failure rate in delayed onset
infection. The monitoring of infections with specific
serum markers is of clinical importance [11] because
reliable biomarkers are essential for decision making
in therapy. CRP has been validated as a sensitive con-
trol parameter for diagnosing infections in arthro-
plasty [24] and for monitoring healing processes
following joint surgery [12]. Our data confirm those
findings, although only the CRP at discharge, but not
initial or maximum CRP values did correspond to the
final outcome. In fact, CRP levels at the day of dis-
charge >20 mg/l (normal ≤5 mg/l) did associate
strongly with the failure of infection clearance. There-
fore, in patients whose implants are infected, this par-
ameter should return to normal levels. Age > 60 years,
smoking, diabetes, previous surgical infections, in-
creased body mass index, and alcohol abuse are
known to be significant preoperative risk factors [25]
for perioperative infections. It had been unclear,
whether these parameters also influence the efficacy of
NPWT therapy. Analysis of our data showed that age,
gender, treatment in an intensive care unit, or co-
morbidities such as metabolic diseases were not asso-
ciated with a higher risk for an unfavorable outcome.
Furthermore, the data from the present study revealed
that the delayed onset of an infection and persistent
high CRP blood levels during therapy correlate nega-
tively with the healing of a postoperative infection.
These effects do not appear to be dependent on the
thickness of the surrounding soft tissue layers or on
the fracture site.
A limitation of the study is that the CIRS was not
primarily designed to identify and evaluate the out-
come parameters we examined (infection cure, types
of wound closure, and implant survival). Further-
more, we consolidated the infected implants in dif-
ferent locations to attain reasonable case numbers to
analyze different factors. The analysis of the comor-
bidity resulted in the same problem, again the case
numbers were too small to reach statistical signifi-
cances regarding diseases known to have more soft
tissue complications. This issue is common when
assessing general treatment strategies in the field of
orthopedic and trauma surgery, because fracture
sites are so diverse and the degree of damage can
also differ. However, these limitations may be bal-
anced in part by applying the appropriate statistical
model for analysis. In the present study, a multiple
regression model was established. This enabled our
results to be adjusted for specific parameters. The
inherent bias of these parameters could thus be min-
imized and the real strength of the correlations iden-
tified. However, the small numbers of patients in
this group may have yielded misleading effects dur-
ing statistical evaluation. Moreover, as no control
group was involved, we cannot claim that the valid-
ity of our findings is limited to the administration of
NPWT therapy for infected osteosynthesis or that
they can be generalized.
As consequence for clinical decision making, a re-
infection rate of almost 30% needs to be seen critically.
Instead of retaining the implant, it might be removed ac-
companied by external fixation and local debridement.
Only in some selected cases it might be worthwhile to
keep the implant, especially in early onset infections
with early diagnosis.
Conclusion
In conclusion, the patient’s age, sex and comorbidities
do not significantly influence the success of NPWT
therapy. The delayed onset of infection, changes in
bacterial strains during treatment, and elevated CRP
levels at discharge do increase the risk for treatment
failure.
Table 5 Logistic regression models on the outcome parameter
“implant survival”
Survival of the implant Multiple logistic regression modela
Influencing Parameter vs. OR [95% CI] p
Bacterial mixture Yes No 5.0 [1.41–17.92] 0.0126
No detectable germ No 3.4 [0.82–14.11] 0.0932
Time point of infection late acute 5.1 [1.93–13.41] 0.0010
Soft tissue damage
Open grade 0–2 Closed 2.6 [0.76–8.78] 0.1262
Open grade 3–4 Closed 10.2 [1.88–55.28] 0.0072
All p-values presented are two-tailed, and p-values lower than 0.05 were con-
sidered statistically significant, 95% confidence level (CI)
aoutcome: implant survival until bony consolidation (yes/no), independent
variables: bacterial mixture (dummy coding (yes/no (reference category)/no
detectable germ), time of infection (postoperative/late onset), and soft tissue
damage (dummy coding (open grade 0–2/open grade 3–4/closed
(reference category)
Fig. 1 The figure provides an overview about the infecting
microbial species
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